Extended Mortality Results for Prostate Cancer Screening in the PLCO Trial with Median 15 Years Follow-up

BACKGROUND: Two large-scale prostate cancer screening trials with prostate-specific antigen (PSA) have given conflicting results in terms of the efficacy of such screening. One of those trials, the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, previously reported outcomes thr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer
Main Authors: Pinsky, Paul F., Prorok, Philip C., Yu, Kelly, Kramer, Barnett S., Black, Amanda, Gohagan, John, Crawford, E. David, Grubb, Robert, Andriole, Gerald
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725951/
https://ncbi.nlm.nih.gov/pubmed/27911486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30474
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares